{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:29Z","timestamp":1792783169552,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal De Minas Gerais","id":[{"id":"https:\/\/ror.org\/0176yjw32","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The hypertrophic cardiomyopathy (HCM) phenotype is the most common feline cardiovascular condition, characterized by myocardial hypertrophy and variable hemodynamic changes, with diagnosis primarily based on echocardiography. However, cardiovascular biomarkers have gained increasing importance in the diagnostic assessment of the HCM phenotype. This systematic review aimed to evaluate the utility of cardiovascular-related biomarkers in the diagnosis of HCM in cats, in order to determine their clinical potential and utility. A systematic search was conducted in PubMed, Scopus, and Web of Science over a last decade (January 2015 \u2013 June 2025). Study selection was performed by a single reviewer, and risk-of-bias assessment by two reviewers using the Joanna Briggs Institute (JBI) tools. Studies providing relevant data on the use of cardiovascular biomarkers in cats with the HCM phenotype were included. Data regarding study design, population characteristics, biomarker type, and clinical associations were extracted and analyzed. Out of 220 initially screened studies, 63 met the inclusion criteria and the majority were considered of high methodological quality with low risk of bias. The most frequently reported biomarkers were N-terminal pro\u2013B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI), both commonly associated with clinical status, echocardiographic findings, and prognostic risk. Other emerging biomarkers, including molecular and genetic markers related to myocardial remodeling and fibrosis, demonstrated potential clinical utility, although further investigation is still required. Overall, despite robust scientific evidence, biomarkers play an adjunctive role in the evaluation of the feline HCM phenotype. Echocardiography remains the gold standard for definitive diagnosis.<\/jats:p>","DOI":"10.1007\/s11259-026-11408-9","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:37:50Z","timestamp":1784281070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular biomarkers in feline hypertrophic cardiomyopathy phenotype: evidence from the last decade"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5078-7820","authenticated-orcid":false,"given":"Felipe Gaia","family":"de Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8005-7426","authenticated-orcid":false,"given":"Ruthnea Aparecida L\u00e1zaro","family":"Muzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-8294","authenticated-orcid":false,"given":"Fernanda do Carmo","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7583-4726","authenticated-orcid":false,"given":"Roberto Baracat","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2747-5535","authenticated-orcid":false,"given":"Rafael Resende","family":"Faleiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-5145","authenticated-orcid":false,"given":"Suzane Lilian","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"11408_CR1","doi-asserted-by":"publisher","first-page":"106441","DOI":"10.1016\/j.tvjl.2025.106441","volume":"314","author":"SW Abdelhaleem","year":"2025","unstructured":"Abdelhaleem SW, Elsharkawy SH, Salem SI, Bashandy MM (2025) Evaluation of some cardiac biomarkers in cats with primary and secondary cardiomyopathies. Vet J 314:106441. https:\/\/doi.org\/10.1016\/j.tvjl.2025.106441","journal-title":"Vet J"},{"key":"11408_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/pharmaceutics15061630","volume":"15","author":"A Ahmad","year":"2023","unstructured":"Ahmad A, Imran M, Ahsan H (2023) Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics 15:1630. https:\/\/doi.org\/10.3390\/pharmaceutics15061630","journal-title":"Pharmaceutics"},{"key":"11408_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.9775\/kvfd.2020.25073","volume":"27","author":"U Bakirel","year":"2021","unstructured":"Bakirel U, Ulgen Saka S, Yildiz K (2021) Role and importance of cardiac biomarkers in diagnosis and prognosis of feline arterial thromboembolism. Kafkas Univ Vet Fak Derg 27:409\u2013415. https:\/\/doi.org\/10.9775\/kvfd.2020.25073","journal-title":"Kafkas Univ Vet Fak Derg"},{"key":"11408_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tvjl.2018.11.005","volume":"243","author":"U Bartoszuk","year":"2019","unstructured":"Bartoszuk U, Keene BW, Baron Toaldo M et al (2019) Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy. Vet J 243:21\u201325. https:\/\/doi.org\/10.1016\/j.tvjl.2018.11.005","journal-title":"Vet J"},{"key":"11408_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jsap.12332","volume":"56","author":"K Borgeat","year":"2015","unstructured":"Borgeat K, Dudhia J, Luis Fuentes V, Connolly DJ (2015a) Circulating concentrations of a marker of type I collagen metabolism are associated with hypertrophic cardiomyopathy mutation status in ragdoll cats. J Small Anim Pract 56:360\u2013365. https:\/\/doi.org\/10.1111\/jsap.12332","journal-title":"J Small Anim Pract"},{"key":"11408_CR6","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1016\/j.jvc.2015.06.005","volume":"17","author":"K Borgeat","year":"2015","unstructured":"Borgeat K, Stern J, Meurs KM et al (2015b) The influence of clinical and genetic factors on left ventricular wall thickness in Ragdoll cats. J Veterinary Cardiol 17:S258\u2013S267. https:\/\/doi.org\/10.1016\/j.jvc.2015.06.005","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR7","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1016\/j.jvc.2015.06.005","volume":"17","author":"K Borgeat","year":"2015","unstructured":"Borgeat K, Stern J, Meurs KM et al (2015c) The influence of clinical and genetic factors on left ventricular wall thickness in Ragdoll cats. J Veterinary Cardiol 17:S258\u2013S267. https:\/\/doi.org\/10.1016\/j.jvc.2015.06.005","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR8","doi-asserted-by":"publisher","DOI":"10.2460\/javma.24.09.0584","author":"BM Brainard","year":"2024","unstructured":"Brainard BM, Coleman AE, Kurosawa A et al (2024) Therapy with clopidogrel or rivaroxaban has equivalent impacts on recurrence of thromboembolism and survival in cats following cardiogenic thromboembolism: the SUPERCAT study. J Am Vet Med Assoc263:1\u201310. https:\/\/doi.org\/10.2460\/javma.24.09.0584","journal-title":"J Am Vet Med Assoc"},{"key":"11408_CR9","doi-asserted-by":"publisher","first-page":"aalaf037","DOI":"10.1093\/jvimsj\/aalaf037","volume":"40","author":"R Carter","year":"2026","unstructured":"Carter R, Partington C, Novo Matos J (2026) Accuracy of combined signalment, physical examination and cardiac biomarkers in screening cats with asymptomatic murmurs for cardiac disease. J Vet Intern Med 40:aalaf037. https:\/\/doi.org\/10.1093\/jvimsj\/aalaf037","journal-title":"J Vet Intern Med"},{"key":"11408_CR10","doi-asserted-by":"publisher","first-page":"105430","DOI":"10.1016\/j.rvsc.2024.105430","volume":"180","author":"A Chong","year":"2024","unstructured":"Chong A, Joshua J, Raheb S et al (2024) Evaluation of potential novel biomarkers for feline hypertrophic cardiomyopathy. Res Vet Sci 180:105430. https:\/\/doi.org\/10.1016\/j.rvsc.2024.105430","journal-title":"Res Vet Sci"},{"key":"11408_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jvc.2020.06.002","volume":"30","author":"AE Coleman","year":"2020","unstructured":"Coleman AE, DeFrancesco TC, Griffiths EH et al (2020) Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers. J Veterinary Cardiol 30:77\u201391. https:\/\/doi.org\/10.1016\/j.jvc.2020.06.002","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR12","doi-asserted-by":"publisher","first-page":"1720886","DOI":"10.3389\/fvets.2025.1720886","volume":"12","author":"FG de Sousa","year":"2025","unstructured":"de Sousa FG, Muzzi RAL, de Ara\u00fajo RB et al (2025) Linking clinical and imaging diagnostic assessments of the feline hypertrophic cardiomyopathy phenotype. Front Vet Sci 12:1720886. https:\/\/doi.org\/10.3389\/fvets.2025.1720886","journal-title":"Front Vet Sci"},{"key":"11408_CR13","doi-asserted-by":"publisher","first-page":"1870206","DOI":"10.3389\/fvets.2026.1870206","volume":"13","author":"FG de Sousa","year":"2026","unstructured":"de Sousa FG, Muzzi RAL, de Ara\u00fajo RB et al (2026) Early activation of Virchow\u2019s triad in feline hypertrophic cardiomyopathy: beyond spontaneous echo contrast and insights into translational thromboembolism. Front Vet Sci 13:1870206. https:\/\/doi.org\/10.3389\/fvets.2026.1870206","journal-title":"Front Vet Sci"},{"key":"11408_CR14","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.14202\/vetworld.2024.2407-2416","volume":"17","author":"K Demeekul","year":"2024","unstructured":"Demeekul K, Sukumolanan P, Petchdee S (2024) Evaluation of galectin-3 and titin in cats with a sarcomeric gene mutation associated with echocardiography. Vet World 17:2407\u20132416. https:\/\/doi.org\/10.14202\/vetworld.2024.2407-2416","journal-title":"Vet World"},{"key":"11408_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jvc.2020.05.001","volume":"30","author":"L Ferasin","year":"2020","unstructured":"Ferasin L, Kilkenny E, Ferasin H (2020) Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy. J Veterinary Cardiol 30:23\u201331. https:\/\/doi.org\/10.1016\/j.jvc.2020.05.001","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.rvsc.2021.03.027","volume":"136","author":"S Fonfara","year":"2021","unstructured":"Fonfara S, Kitz S, Monteith G et al (2021) Myocardial transcription of inflammatory and remodeling markers in cats with hypertrophic cardiomyopathy and systemic diseases associated with an inflammatory phenotype. Res Vet Sci 136:484\u2013494. https:\/\/doi.org\/10.1016\/j.rvsc.2021.03.027","journal-title":"Res Vet Sci"},{"key":"11408_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1939-1676.2011.00776.x","volume":"25","author":"PR Fox","year":"2011","unstructured":"Fox PR, Rush JE, Reynolds CA et al (2011) Multicenter evaluation of plasma N-Terminal Probrain Natriuretic Peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats. J Vet Intern Med 25:1010\u20131016. https:\/\/doi.org\/10.1111\/j.1939-1676.2011.00776.x","journal-title":"J Vet Intern Med"},{"key":"11408_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jvim.15122","volume":"32","author":"PR Fox","year":"2018","unstructured":"Fox PR, Keene BW, Lamb K et al (2018) International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study. J Vet Intern Med 32:930\u2013943. https:\/\/doi.org\/10.1111\/jvim.15122","journal-title":"J Vet Intern Med"},{"key":"11408_CR17","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/jvim.15609","volume":"33","author":"PR Fox","year":"2019","unstructured":"Fox PR, Keene BW, Lamb K et al (2019) Long-term incidence and risk of noncardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy. J Vet Intern Med 33:2572\u20132586. https:\/\/doi.org\/10.1111\/jvim.15609","journal-title":"J Vet Intern Med"},{"key":"11408_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/jvim.12503","volume":"29","author":"LM Freeman","year":"2015","unstructured":"Freeman LM, Rush JE, Feugier A, van Hoek I (2015) Relationship of body size to metabolic markers and left ventricular hypertrophy in cats. J Vet Intern Med 29:150\u2013156. https:\/\/doi.org\/10.1111\/jvim.12503","journal-title":"J Vet Intern Med"},{"key":"11408_CR21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.cvsm.2023.05.010","volume":"53","author":"R Fries","year":"2023","unstructured":"Fries R (2023) Hypertrophic cardiomyopathy\u2013advances in imaging and diagnostic strategies. veterinary clinics of North America -. Small Anim Pract 53:1325\u20131342. https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.010","journal-title":"Small Anim Pract"},{"key":"11408_CR22","doi-asserted-by":"publisher","unstructured":"Fries RC, Kadotani S, Stack JP et al (2022) Prognostic value of neutrophil-to-lymphocyte ratio in cats with hypertrophic cardiomyopathy. Front Vet Sci 9:813524. https:\/\/doi.org\/10.3389\/fvets.2022.813524","DOI":"10.3389\/fvets.2022.813524"},{"key":"11408_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/vetsci12030289","volume":"12","author":"F Gaia de Sousa","year":"2025","unstructured":"Gaia de Sousa F, Mendes ACR, de Carvalho LP, Beier SL (2025) Clinical-diagnostic and therapeutic advances in feline hypertrophic cardiomyopathy. Vet Sci 12:289. https:\/\/doi.org\/10.3390\/vetsci12030289","journal-title":"Vet Sci"},{"key":"11408_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/vetsci803","volume":"8","author":"A Gavazza","year":"2021","unstructured":"Gavazza A, Marchegiani A, Guerriero L et al (2021) Updates on Laboratory Evaluation of Feline Cardiac Diseases. Vet Sci 8:41. https:\/\/doi.org\/10.3390\/vetsci803","journal-title":"Vet Sci"},{"key":"11408_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/iep.12514","volume":"105","author":"G Guelfi","year":"2024","unstructured":"Guelfi G, Venanzi N, Capaccia C et al (2024) Feline hypertrophic cardiomyopathy: Does the microRNA-mRNA regulatory network contribute to heart sarcomeric protein remodelling? Int J Exp Pathol 105:170\u2013183. https:\/\/doi.org\/10.1111\/iep.12514","journal-title":"Int J Exp Pathol"},{"key":"11408_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1098612X241257878","volume":"26","author":"J Guillaumin","year":"2024","unstructured":"Guillaumin J (2024) Feline Aortic Thromboembolism: recent advances and future prospects. J Feline Med Surg 26:1\u201313. https:\/\/doi.org\/10.1177\/1098612X241257878","journal-title":"J Feline Med Surg"},{"key":"11408_CR27","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/jvim.15754","volume":"34","author":"S Han\u00e5s","year":"2020","unstructured":"Han\u00e5s S, Holst BS, H\u00f6glund K et al (2020) Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test. J Vet Intern Med 34:1187\u20131197. https:\/\/doi.org\/10.1111\/jvim.15754","journal-title":"J Vet Intern Med"},{"key":"11408_CR28","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1177\/1098612X221117115","volume":"24","author":"S Han\u00e5s","year":"2022","unstructured":"Han\u00e5s S, Larsson A, Ryd\u00e9n J et al (2022) Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy. J Feline Med Surg 24:e370\u2013e379. https:\/\/doi.org\/10.1177\/1098612X221117115","journal-title":"J Feline Med Surg"},{"key":"11408_CR29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/jvim.14776","volume":"31","author":"AN Harris","year":"2017","unstructured":"Harris AN, Beatty SS, Estrada AH et al (2017) Investigation of an N-Terminal prohormone of brain natriuretic peptide point-of-care ELISA in clinically normal cats and cats with cardiac disease. J Vet Intern Med 31:994\u2013999. https:\/\/doi.org\/10.1111\/jvim.14776","journal-title":"J Vet Intern Med"},{"key":"11408_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jvc.2018.04.008","volume":"20","author":"Y Heishima","year":"2018","unstructured":"Heishima Y, Hori Y, Nakamura K et al (2018) Diagnostic accuracy of plasma atrial natriuretic peptide concentrations in cats with and without cardiomyopathies. J Veterinary Cardiol 20:234\u2013243. https:\/\/doi.org\/10.1016\/j.jvc.2018.04.008","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1892\/0891-6640(2002)016<0558:CTIIFH>2.3.CO;2","volume":"16","author":"WE Herndon","year":"2002","unstructured":"Herndon WE, Kittleson MD, Sanderson K et al (2002) Cardiac troponin I in feline hypertrophic cardiomyopathy. J Vet Intern Med 16:558\u2013564. https:\/\/doi.org\/10.1892\/0891-6640(2002)016%3C0558:ctiifh%3E2.3.co;2","journal-title":"J Vet Intern Med"},{"key":"11408_CR32","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/jvim.15498","volume":"33","author":"S Hertzsch","year":"2019","unstructured":"Hertzsch S, Roos A, Wess G (2019) Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats. J Vet Intern Med 33:1242\u20131250. https:\/\/doi.org\/10.1111\/jvim.15498","journal-title":"J Vet Intern Med"},{"key":"11408_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jvim.13831","volume":"30","author":"MJ Hezzell","year":"2016","unstructured":"Hezzell MJ, Rush JE, Humm K et al (2016) Differentiation of cardiac from noncardiac pleural effusions in cats using second-generation quantitative and Point-of-Care NT-proBNP measurements. J Vet Intern Med 30:536\u2013542. https:\/\/doi.org\/10.1111\/jvim.13831","journal-title":"J Vet Intern Med"},{"key":"11408_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.cvsm.2017.05.001","volume":"47","author":"DF Hogan","year":"2017","unstructured":"Hogan DF (2017) Feline cardiogenic arterial thromboembolism: prevention and therapy. Veterinary Clinics of North America. - Small Anim Pract 47:1065\u20131082. https:\/\/doi.org\/10.1016\/j.cvsm.2017.05.001","journal-title":"- Small Anim Pract"},{"key":"11408_CR35","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.1016\/j.jvc.2015.10.004","volume":"17","author":"DF Hogan","year":"2015","unstructured":"Hogan DF, Fox PR, Jacob K et al (2015) Secondary prevention of cardiogenic arterial thromboembolism in the cat: The double-blind, randomized, positive-controlled feline arterial thromboembolism; Clopidogrel vs. aspirin trial (FAT CAT). J Veterinary Cardiol 17:S306\u2013S317. https:\/\/doi.org\/10.1016\/j.jvc.2015.10.004","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jvim.15131","volume":"32","author":"Y Hori","year":"2018","unstructured":"Hori Y, Iguchi M, Heishima Y et al (2018) Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy. J Vet Intern Med 32:922\u2013929. https:\/\/doi.org\/10.1111\/jvim.15131","journal-title":"J Vet Intern Med"},{"key":"11408_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jvc.2020.04.002","volume":"29","author":"Y Hori","year":"2020","unstructured":"Hori Y, Fujimoto E, Nishikawa Y, Nakamura T (2020) Left ventricular outflow tract pressure gradient changes after carvedilol\u2013disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy. J Veterinary Cardiol 29:40\u201346. https:\/\/doi.org\/10.1016\/j.jvc.2020.04.002","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvc.2009.02.005","author":"A Hsu","year":"2009","unstructured":"Hsu A, Kittleson MD, Paling A (2009) Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy. J Veterinary Cardiol 11:S63\u201370. https:\/\/doi.org\/10.1016\/j.jvc.2009.02.005","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1098612X20938651","volume":"23","author":"V Ironside","year":"2021","unstructured":"Ironside V, Tricklebank P, Boswood A (2021) Risk indictors in cats with preclinical hypertrophic cardiomyopathy: a prospective cohort study. J Feline Med Surg 23:149\u2013159. https:\/\/doi.org\/10.1177\/1098612X20938651","journal-title":"J Feline Med Surg"},{"key":"11408_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01652176.2023.2234436","volume":"43","author":"I Janus","year":"2023","unstructured":"Janus I, Noszczyk-Nowak A, Bubak J et al (2023) Comparative cardiac macroscopic and microscopic study in cats with hyperthyroidism vs. cats with hypertrophic cardiomyopathy. Veterinary Q 43:1\u201311. https:\/\/doi.org\/10.1080\/01652176.2023.2234436","journal-title":"Veterinary Q"},{"key":"11408_CR41","doi-asserted-by":"publisher","unstructured":"Jiwaganont P, Roytrakul S, Thaisakun S et al (2024) Investigation of coagulation and proteomics profiles in symptomatic feline hypertrophic cardiomyopathy and healthy control cats. BMC Vet Res 20:292. https:\/\/doi.org\/10.1186\/s12917-024-04170-0","DOI":"10.1186\/s12917-024-04170-0"},{"key":"11408_CR42","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/jvim.17050","volume":"38","author":"AJ Johnson","year":"2024","unstructured":"Johnson AJ, Rozanski EA, de Laforcade AM et al (2024) Viscoelastic coagulation monitoring parameters in cats with acute arterial thromboembolism. J Vet Intern Med 38:2045\u20132051. https:\/\/doi.org\/10.1111\/jvim.17050","journal-title":"J Vet Intern Med"},{"key":"11408_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmccpl.2023.100037","author":"J Joshua","year":"2023","unstructured":"Joshua J, Caswell JL, Monn\u00e9 Rodriguez JM et al (2023) MicroRNA profiling of the feline left heart identifies chamber-specific expression signatures in health and in advanced hypertrophic cardiomyopathy. J Mol Cell Cardiol Plus 4:100037. https:\/\/doi.org\/10.1016\/j.jmccpl.2023.100037","journal-title":"J Mol Cell Cardiol Plus"},{"key":"11408_CR43","doi-asserted-by":"publisher","unstructured":"Joshua J, Caswell JL, Kipar A et al (2025) Integrated MicroRNA\u2013mRNA sequencing analysis identifies regulators and networks involved in feline hypertrophic cardiomyopathy. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26146764","DOI":"10.3390\/ijms26146764"},{"key":"11408_CR46","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.2460\/javma.23.04.0187","volume":"261","author":"JL Kaplan","year":"2023","unstructured":"Kaplan JL, Rivas VN, Walker AL et al (2023) Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial. J Am Vet Med Assoc 261:1628\u20131637. https:\/\/doi.org\/10.2460\/javma.23.04.0187","journal-title":"J Am Vet Med Assoc"},{"key":"11408_CR45","doi-asserted-by":"publisher","unstructured":"Kaplan JL, Rivas VN, Vandewege MW et al (2025) Unraveling the genetics of feline hypertrophic cardiomyopathy: a multiomics study of 138 cats. G3: Genes, Genomes Genet 15:jkaf153. https:\/\/doi.org\/10.1093\/g3journal\/jkaf153","DOI":"10.1093\/g3journal\/jkaf153"},{"key":"11408_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1098612x231154859","volume":"25","author":"SI Karp","year":"2023","unstructured":"Karp SI, Freeman LM, Rush JE et al (2023) Comparison of echocardiography, biomarkers and taurine concentrations in cats eating high- or low-pulse diets. J Feline Med Surg 25:1\u20139. https:\/\/doi.org\/10.1177\/1098612x231154859","journal-title":"J Feline Med Surg"},{"key":"11408_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.51585\/gjvr.2022.4.0044","volume":"2","author":"Y Kaya","year":"2022","unstructured":"Kaya Y, Bak\u0131rel U (2022) Assessment of soluble ST2 as a novel cardiac biomarker in cats with cardiomyopathy. German J Veterinary Res 2:1\u20137. https:\/\/doi.org\/10.51585\/gjvr.2022.4.0044","journal-title":"German J Veterinary Res"},{"key":"11408_CR49","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1177\/1098612X211020162","volume":"23","author":"MD Kittleson","year":"2021","unstructured":"Kittleson MD, C\u00f4t\u00e9 E (2021a) The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy. J Feline Med Surg 23:1028\u20131051. https:\/\/doi.org\/10.1177\/1098612X211020162","journal-title":"J Feline Med Surg"},{"key":"11408_CR50","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/1098612X211021819","volume":"23","author":"MD Kittleson","year":"2021","unstructured":"Kittleson MD, C\u00f4t\u00e9 E (2021b) The Feline Cardiomyopathies: 1. General concepts. J Feline Med Surg 23:1009\u20131027. https:\/\/doi.org\/10.1177\/1098612X211021819","journal-title":"J Feline Med Surg"},{"key":"11408_CR53","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/jvim.12407","volume":"28","author":"R Langhorn","year":"2014","unstructured":"Langhorn R, Tarnow I, Willesen JL et al (2014) Cardiac Troponin I and T as prognostic markers in cats with hypertrophic cardiomyopathy. J Vet Intern Med 28:1485\u20131491. https:\/\/doi.org\/10.1111\/jvim.12407","journal-title":"J Vet Intern Med"},{"key":"11408_CR54","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/vr.103549","volume":"178","author":"R Langhorn","year":"2016","unstructured":"Langhorn R, Willesen JL, Tarnow I et al (2016) Cardiac troponin I in three cat breeds with hypertrophic cardiomyopathy. Vet Rec 178:532. https:\/\/doi.org\/10.1136\/vr.103549","journal-title":"Vet Rec"},{"key":"11408_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jvim.14902","volume":"32","author":"R Langhorn","year":"2018","unstructured":"Langhorn R, Kieler IN, Koch J et al (2018) Symmetric dimethylarginine in cats with hypertrophic cardiomyopathy and diabetes mellitus. J Vet Intern Med 32:57\u201363. https:\/\/doi.org\/10.1111\/jvim.14902","journal-title":"J Vet Intern Med"},{"key":"11408_CR51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1098612X18813427","volume":"21","author":"R Langhorn","year":"2019","unstructured":"Langhorn R, Jessen LR, Kloster AS et al (2019) Cardiac troponin I in cats with compromised renal function. J Feline Med Surg 21:985\u2013991. https:\/\/doi.org\/10.1177\/1098612X18813427","journal-title":"J Feline Med Surg"},{"key":"11408_CR55","doi-asserted-by":"publisher","first-page":"872","DOI":"10.14202\/vetworld.2020.872-878","volume":"13","author":"T Laudhittirut","year":"2020","unstructured":"Laudhittirut T, Rujivipat N, Saringkarisate K et al (2020) Accuracy of methods for diagnosing heart diseases in cats. Vet World 13:872\u2013878. https:\/\/doi.org\/10.14202\/vetworld.2020.872-878","journal-title":"Vet World"},{"key":"11408_CR57","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/jvim.16676","volume":"37","author":"RHL Li","year":"2023","unstructured":"Li RHL, Fabella A, Nguyen N et al (2023) Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism. J Vet Intern Med 37:490\u2013502. https:\/\/doi.org\/10.1111\/jvim.16676","journal-title":"J Vet Intern Med"},{"key":"11408_CR56","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/ehf2.15135","volume":"12","author":"Q Li","year":"2025","unstructured":"Li Q, Homilius M, Achilles E et al (2025) Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy. ESC Heart Fail 12:1256\u20131270. https:\/\/doi.org\/10.1002\/ehf2.15135","journal-title":"ESC Heart Fail"},{"key":"11408_CR58","doi-asserted-by":"publisher","first-page":"e0346522","DOI":"10.1371\/journal.pone.0346522","volume":"21","author":"JA Lidbury","year":"2026","unstructured":"Lidbury JA, Meyers RC, Saunders AB et al (2026) Analytical validation and clinical evaluation of a high-sensitivity cardiac troponin I immunoassay for use in cats. PLoS ONE 21:e0346522. https:\/\/doi.org\/10.1371\/journal.pone.0346522","journal-title":"PLoS ONE"},{"key":"11408_CR60","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/jvim.15757","volume":"34","author":"M Liu","year":"2020","unstructured":"Liu M, K\u00f6ster LS, Fosgate GT et al (2020) Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy. J Vet Intern Med 34:1078\u20131090. https:\/\/doi.org\/10.1111\/jvim.15757","journal-title":"J Vet Intern Med"},{"key":"11408_CR59","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7150\/ijms.50167","volume":"18","author":"L Liu","year":"2021","unstructured":"Liu L, Liu Z, Chen X, He S (2021) Thromboembolism in patients with hypertrophic cardiomyopathy. Int J Med Sci 18:727\u2013735. https:\/\/doi.org\/10.7150\/ijms.50167","journal-title":"Int J Med Sci"},{"key":"11408_CR61","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/jvim.15549","volume":"33","author":"KA Loughran","year":"2019","unstructured":"Loughran KA, Rush JE, Rozanski EA et al (2019) The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats. J Vet Intern Med 33:1892\u20131901. https:\/\/doi.org\/10.1111\/jvim.15549","journal-title":"J Vet Intern Med"},{"key":"11408_CR62","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/jvim.16156","volume":"35","author":"TL Lu","year":"2021","unstructured":"Lu TL, C\u00f4t\u00e9 E, Kuo YW et al (2021) Point-of-care N-terminal pro B-type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice. J Vet Intern Med 35:1663\u20131672. https:\/\/doi.org\/10.1111\/jvim.16156","journal-title":"J Vet Intern Med"},{"key":"11408_CR64","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cvsm.2017.05.002","volume":"47","author":"V Luis Fuentes","year":"2017","unstructured":"Luis Fuentes V, Wilkie LJ (2017) Asymptomatic hypertrophic cardiomyopathy: diagnosis and therapy. Veterinary Clinics of North America. - Small Anim Pract 47:1041\u20131054. https:\/\/doi.org\/10.1016\/j.cvsm.2017.05.002","journal-title":"- Small Anim Pract"},{"key":"11408_CR63","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/jvim.15745","volume":"34","author":"V Luis Fuentes","year":"2020","unstructured":"Luis Fuentes V, Abbott J, Chetboul V et al (2020) ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. J Vet Intern Med 34:1062\u20131077. https:\/\/doi.org\/10.1111\/jvim.15745","journal-title":"J Vet Intern Med"},{"key":"11408_CR65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jvc.2014.09.002","volume":"16","author":"MC Machen","year":"2014","unstructured":"Machen MC, Oyama MA, Gordon SG et al (2014) Multi-centered investigation of a point-of-care NT-proBNP ELISA assay to detect moderate to severe occult (pre-clinical) feline heart disease in cats referred for cardiac evaluation. J Veterinary Cardiol 16:245\u2013255. https:\/\/doi.org\/10.1016\/j.jvc.2014.09.002","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR66","doi-asserted-by":"publisher","unstructured":"Maclean HN, Abbott JA, Ward DL et al (2006) N-Terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 20:284\u2013289. https:\/\/doi.org\/10.1892\/0891-6640(2006)20[284:nanpii]2.0.co;2","DOI":"10.1892\/0891-6640(2006)20[284:nanpii]2.0.co;2"},{"key":"11408_CR67","doi-asserted-by":"publisher","unstructured":"McNamara JW, Schuckman M, Becker RC, Sadayappan S (2020) A novel homozygous intronic variant in TNNT2 associates with feline cardiomyopathy. Front Physiol 11:608473. https:\/\/doi.org\/10.3389\/fphys.2020.608473","DOI":"10.3389\/fphys.2020.608473"},{"key":"11408_CR68","doi-asserted-by":"publisher","unstructured":"Messer AE, Chan J, Daley A et al (2017) Investigations into the sarcomeric protein and Ca2+-regulation abnormalities underlying hypertrophic cardiomyopathy in cats (Felix catus). Front Physiol 8:348. https:\/\/doi.org\/10.3389\/fphys.2017.00348","DOI":"10.3389\/fphys.2017.00348"},{"key":"11408_CR70","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/hmg\/ddi386","volume":"14","author":"KM Meurs","year":"2005","unstructured":"Meurs KM, Sanchez X, David RM et al (2005) A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet 14:3587\u20133593. https:\/\/doi.org\/10.1093\/hmg\/ddi386","journal-title":"Hum Mol Genet"},{"key":"11408_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ygeno.2007.04.007","volume":"90","author":"KM Meurs","year":"2007","unstructured":"Meurs KM, Norgard MM, Ederer MM et al (2007) A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy. Genomics 90:261\u2013264. https:\/\/doi.org\/10.1016\/j.ygeno.2007.04.007","journal-title":"Genomics"},{"key":"11408_CR71","doi-asserted-by":"publisher","unstructured":"Netala VR, Hou T, Wang Y et al (2025) Cardiovascular biomarkers: tools for precision diagnosis and prognosis. Int J Mol Sci 26:3218. https:\/\/doi.org\/10.3390\/ijms26073218","DOI":"10.3390\/ijms26073218"},{"key":"11408_CR72","doi-asserted-by":"publisher","unstructured":"Neumann S (2025) Serum Concentrations of Insulin-like Growth Factor-1 (IGF-1), 26S Proteasome (26S PSM), and 3-Methylhistidine (3-MH) in Cats with Hypertrophic Cardiomyopathy. Animals 15:1437. https:\/\/doi.org\/10.3390\/ani15101437","DOI":"10.3390\/ani15101437"},{"key":"11408_CR73","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.cvsm.2023.05.012","volume":"53","author":"J Novo Matos","year":"2023","unstructured":"Novo Matos J, Payne JR (2023) Predicting development of hypertrophic cardiomyopathy and disease outcomes in cats. Veterinary Clin North Am - Small Anim Pract 53:1277\u20131292. https:\/\/doi.org\/10.1016\/j.cvsm.2023.05.012","journal-title":"Veterinary Clin North Am - Small Anim Pract"},{"key":"11408_CR76","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jvim.14897","volume":"32","author":"J Novo Matos","year":"2018","unstructured":"Novo Matos J, Pereira N, Glaus T et al (2018) Transient myocardial thickening in cats associated with heart failure. J Vet Intern Med 32:48\u201356. https:\/\/doi.org\/10.1111\/jvim.14897","journal-title":"J Vet Intern Med"},{"key":"11408_CR75","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/jvim.16576","volume":"36","author":"J Novo Matos","year":"2022","unstructured":"Novo Matos J, Payne JR, Seo J, Luis Fuentes V (2022) Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study. J Vet Intern Med 36:1900\u20131912. https:\/\/doi.org\/10.1111\/jvim.16576","journal-title":"J Vet Intern Med"},{"key":"11408_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jvc.2023.09.006","volume":"50","author":"J Novo Matos","year":"2023","unstructured":"Novo Matos J, Payne JR, Mullins J, Luis Fuentes V (2023a) Isolated discrete upper septal thickening in a non-referral cat population of senior and young cats. J Veterinary Cardiol 50:39\u201350. https:\/\/doi.org\/10.1016\/j.jvc.2023.09.006","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jvc.2023.02.002","volume":"46","author":"J Novo Matos","year":"2023","unstructured":"Novo Matos J, Sargent J, Silva J et al (2023b) Thin and hypokinetic myocardial segments in cats with cardiomyopathy. J Veterinary Cardiol 46:5\u201317. https:\/\/doi.org\/10.1016\/j.jvc.2023.02.002","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR81","doi-asserted-by":"publisher","first-page":"no","DOI":"10.1002\/vetr.945","volume":"191","author":"S O\u2019Shaughnessy","year":"2021","unstructured":"O\u2019Shaughnessy S, Crawford I, Arsevska E et al (2021) Clinical findings associated with N-terminal pro-B-type natriuretic peptide measurement in dogs and cats attending first opinion veterinary practices. Vet Rec 191:e945. https:\/\/doi.org\/10.1002\/vetr.945","journal-title":"Vet Rec"},{"key":"11408_CR78","doi-asserted-by":"publisher","unstructured":"Ohlsson \u00c5, Han\u00e5s S, Holst BS et al (2025) Profiling of the microRNA transcriptome in feline whole blood. Sci Rep 15:27962. https:\/\/doi.org\/10.1038\/s41598-025-09478-x","DOI":"10.1038\/s41598-025-09478-x"},{"key":"11408_CR79","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1177\/1098612X18816460","volume":"21","author":"ES Ontiveros","year":"2019","unstructured":"Ontiveros ES, Ueda Y, Harris SP, Stern JA (2019) Precision medicine validation: identifying the MYBPC3 A31P variant with whole-genome sequencing in two Maine Coon cats with hypertrophic cardiomyopathy. J Feline Med Surg 21:1086\u20131093. https:\/\/doi.org\/10.1177\/1098612X18816460","journal-title":"J Feline Med Surg"},{"key":"11408_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/ani16020157","volume":"16","author":"MA Oranges","year":"2026","unstructured":"Oranges MA, Freeman LM, Rozanski EA et al (2026) Comparison of N-Terminal Pro-B-Type natriuretic peptide between cats with cardiogenic arterial thromboembolism and cats with occult cardiomyopathy without arterial thromboembolism. Animals 16:157. https:\/\/doi.org\/10.3390\/ani16020157","journal-title":"Animals"},{"key":"11408_CR82","doi-asserted-by":"publisher","unstructured":"Partington C, Hodgkiss-Geere H, Woods GRT et al (2024) The effect of obesity and subsequent weight reduction on cardiac morphology and function in cats. BMC Vet Res 20:154. https:\/\/doi.org\/10.1186\/s12917-024-04011-0","DOI":"10.1186\/s12917-024-04011-0"},{"key":"11408_CR83","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1515\/pjvs-2016-0101","volume":"19","author":"M Parzeniecka-Jaworska","year":"2016","unstructured":"Parzeniecka-Jaworska M, Garncarz M, Kluci\u0144ski W (2016) ProANP as a screening biomarker for hypertrophic cardiomyopathy in Maine coon cats. Pol J Vet Sci 19:801\u2013807. https:\/\/doi.org\/10.1515\/pjvs-2016-0101","journal-title":"Pol J Vet Sci"},{"key":"11408_CR84","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1748-5827.2010.00989.x","volume":"51","author":"J Payne","year":"2010","unstructured":"Payne J, Luis Fuentes V, Boswood A et al (2010) Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005). J Small Anim Pract 51:540\u2013547. https:\/\/doi.org\/10.1111\/j.1748-5827.2010.00989.x","journal-title":"J Small Anim Pract"},{"key":"11408_CR85","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/jvim.12215","volume":"27","author":"JR Payne","year":"2013","unstructured":"Payne JR, Borgeat K, Connolly DJ et al (2013) Prognostic indicators in cats with hypertrophic cardiomyopathy. J Vet Intern Med 27:1427\u20131436. https:\/\/doi.org\/10.1111\/jvim.12215","journal-title":"J Vet Intern Med"},{"key":"11408_CR86","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.1016\/j.jvc.2015.03.008","volume":"17","author":"JR Payne","year":"2015","unstructured":"Payne JR, Brodbelt DC, Luis Fuentes V (2015) Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Veterinary Cardiol 17:S244\u2013S257. https:\/\/doi.org\/10.1016\/j.jvc.2015.03.008","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR87","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/jvim.14690","volume":"31","author":"KV Pierce","year":"2017","unstructured":"Pierce KV, Rush JE, Freeman LM et al (2017) Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure. J Vet Intern Med 31:678\u2013684. https:\/\/doi.org\/10.1111\/jvim.14690","journal-title":"J Vet Intern Med"},{"key":"11408_CR88","doi-asserted-by":"publisher","unstructured":"Raffle J, Novo Matos J, Wallace M et al (2025) Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing. Sci Rep 15:3871. https:\/\/doi.org\/10.1038\/s41598-025-87852-5","DOI":"10.1038\/s41598-025-87852-5"},{"key":"11408_CR89","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/1098612X16649988","volume":"19","author":"KV Roderick","year":"2017","unstructured":"Roderick KV, Abelson AL, Nielsen L et al (2017) Evaluation of red blood cell distribution width as a prognostic indicator in cats with acquired heart disease, with and without congestive heart failure. J Feline Med Surg 19:648\u2013656. https:\/\/doi.org\/10.1177\/1098612X16649988","journal-title":"J Feline Med Surg"},{"key":"11408_CR90","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/jvim.15777","volume":"34","author":"MN Rohrbaugh","year":"2020","unstructured":"Rohrbaugh MN, Schober KE, Rhinehart JD et al (2020) Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy. J Vet Intern Med 34:1091\u20131101. https:\/\/doi.org\/10.1111\/jvim.15777","journal-title":"J Vet Intern Med"},{"key":"11408_CR91","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jvim.12259","volume":"28","author":"JK Sangster","year":"2014","unstructured":"Sangster JK, Panciera DL, Abbott JA et al (2014) Cardiac biomarkers in hyperthyroid cats. J Vet Intern Med 28:465\u2013472. https:\/\/doi.org\/10.1111\/jvim.12259","journal-title":"J Vet Intern Med"},{"key":"11408_CR92","doi-asserted-by":"publisher","unstructured":"Saponaro V, Alvarado MP, Ghazal S (2025) Left ventricular outpouching with an intracavitary thrombus in a cat with end-stage hypertrophic cardiomyopathy. Vet Rec Case Rep 13:e1068. https:\/\/doi.org\/10.1002\/vrc2.1073","DOI":"10.1002\/vrc2.1073"},{"key":"11408_CR93","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2460\/javma.256.9.984","volume":"256","author":"F Sarcinella","year":"2020","unstructured":"Sarcinella F, Dukes-McEwan J, Bode EF, Santilli RA (2020) ECG Month. J Am Vet Med Assoc 256:984\u2013988. https:\/\/doi.org\/10.2460\/javma.256.9.984","journal-title":"J Am Vet Med Assoc"},{"key":"11408_CR94","doi-asserted-by":"publisher","unstructured":"Satomi S, Suzuki R, Yuchi Y et al (2025) Relationship between cardiac Troponin I concentration and myocardial function in hypertrophic cardiomyopathy cats with or without left ventricular outflow tract obstruction. Animals 15:1313. https:\/\/doi.org\/10.3390\/ani15091313","DOI":"10.3390\/ani15091313"},{"key":"11408_CR95","doi-asserted-by":"publisher","unstructured":"Satomi S, Suzuki R, Yuchi Y et al (2026) Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy. J Feline Med Surg 28:1098612X261433060. https:\/\/doi.org\/10.1177\/1098612X261433060","DOI":"10.1177\/1098612X261433060"},{"key":"11408_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20551169231166528","volume":"9","author":"K Seddon","year":"2023","unstructured":"Seddon K, Serra IC, Seo J (2023) Flash pulmonary oedema associated with paroxysmal supraventricular tachycardia: report of two cases. J Feline Med Surg 9:1\u20136. https:\/\/doi.org\/10.1177\/20551169231166528","journal-title":"J Feline Med Surg"},{"key":"11408_CR100","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/jvim.15807","volume":"34","author":"J Seo","year":"2020","unstructured":"Seo J, Payne JR, Novo Matos J et al (2020) Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy. J Vet Intern Med 34:1718\u20131727. https:\/\/doi.org\/10.1111\/jvim.15807","journal-title":"J Vet Intern Med"},{"key":"11408_CR97","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jvc.2024.05.003","volume":"54","author":"J Seo","year":"2024","unstructured":"Seo J, Kurosawa TA, Borgeat K et al (2024a) Clinical signs associated with severe ST segment elevation in three cats with a hypertrophic cardiomyopathy phenotype. J Veterinary Cardiol 54:30\u201337. https:\/\/doi.org\/10.1016\/j.jvc.2024.05.003","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR98","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1111\/jvim.17203","volume":"38","author":"J Seo","year":"2024","unstructured":"Seo J, Novo Matos J, Munday JS et al (2024b) Longitudinal assessment of systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy. J Vet Intern Med 38:2982\u20132993. https:\/\/doi.org\/10.1111\/jvim.17203","journal-title":"J Vet Intern Med"},{"key":"11408_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00480169.2024.2404684","volume":"73","author":"J Seo","year":"2025","unstructured":"Seo J, Owen R, Hunt H et al (2025) Prevalence of cardiomyopathy and cardiac mortality in a colony of non-purebred cats in New Zealand. N Z Vet J 73:1\u20139. https:\/\/doi.org\/10.1080\/00480169.2024.2404684","journal-title":"N Z Vet J"},{"key":"11408_CR101","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jvc.2023.04.005","volume":"47","author":"M Sidler","year":"2023","unstructured":"Sidler M, Santarelli G, Kovacevic A et al (2023) Ventricular pre-excitation in cats: 17 cases. J Veterinary Cardiol 47:70\u201382. https:\/\/doi.org\/10.1016\/j.jvc.2023.04.005","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR102","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jfms.2010.08.004","volume":"12","author":"MK Singh","year":"2010","unstructured":"Singh MK, Cocchiaro MF, Kittleson MD (2010) NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats. J Feline Med Surg 12:942\u2013947. https:\/\/doi.org\/10.1016\/j.jfms.2010.08.004","journal-title":"J Feline Med Surg"},{"key":"11408_CR103","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tvjl.2015.07.015","volume":"206","author":"PF Solter","year":"2015","unstructured":"Solter PF, Oyama MA, Machen MC et al (2015) Detection by ELISA of C-terminal proBNP in plasma from cats with cardiomyopathy. Vet J 206:213\u2013217. https:\/\/doi.org\/10.1016\/j.tvjl.2015.07.015","journal-title":"Vet J"},{"key":"11408_CR104","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jvc.2023.06.003","volume":"48","author":"JP Stack","year":"2023","unstructured":"Stack JP, Fries RC, Kruckman L et al (2023) Galectin-3 as a novel biomarker in cats with hypertrophic cardiomyopathy. J Veterinary Cardiol 48:54\u201362. https:\/\/doi.org\/10.1016\/j.jvc.2023.06.003","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR105","doi-asserted-by":"publisher","unstructured":"Stern JA, Rivas VN, Kaplan JL et al (2023) Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C. Sci Rep 13:10319. https:\/\/doi.org\/10.1038\/s41598-023-36932-5","DOI":"10.1038\/s41598-023-36932-5"},{"key":"11408_CR106","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.5455\/OVJ.2024.v14.i9.29","volume":"14","author":"N Tantitamtaworn","year":"2024","unstructured":"Tantitamtaworn N, Adisaisakundet I, Chairit K et al (2024) Parameters related to diagnosing hypertrophic cardiomyopathy in cats. Open Vet J 14:2407\u20132414. https:\/\/doi.org\/10.5455\/OVJ.2024.v14.i9.29","journal-title":"Open Vet J"},{"key":"11408_CR107","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/jvim.15730","volume":"34","author":"I van Hoek","year":"2020","unstructured":"van Hoek I, Hodgkiss-Geere H, Bode EF et al (2020a) Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy. J Vet Intern Med 34:591\u2013599. https:\/\/doi.org\/10.1111\/jvim.15730","journal-title":"J Vet Intern Med"},{"key":"11408_CR108","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/jvim.15925","volume":"34","author":"I van Hoek","year":"2020","unstructured":"van Hoek I, Hodgkiss-Geere H, Bode EF et al (2020b) Association of diet with left ventricular wall thickness, troponin I and IGF-1 in cats with subclinical hypertrophic cardiomyopathy. J Vet Intern Med 34:2197\u20132210. https:\/\/doi.org\/10.1111\/jvim.15925","journal-title":"J Vet Intern Med"},{"key":"11408_CR109","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jvc.2020.03.002","volume":"28","author":"T Vezzosi","year":"2020","unstructured":"Vezzosi T, Buralli C, Briganti A et al (2020) Surgical embolectomy in a cat with cardiogenic aortic thromboembolism. J Veterinary Cardiol 28:48\u201354. https:\/\/doi.org\/10.1016\/j.jvc.2020.03.002","journal-title":"J Veterinary Cardiol"},{"key":"11408_CR110","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/jvim.15246","volume":"32","author":"JL Ward","year":"2018","unstructured":"Ward JL, Lisciandro GR, Ware WA et al (2018) Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress. J Vet Intern Med 32:1530\u20131540. https:\/\/doi.org\/10.1111\/jvim.15246","journal-title":"J Vet Intern Med"},{"key":"11408_CR111","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1939-165X.2011.00305.x","volume":"40","author":"G Wess","year":"2011","unstructured":"Wess G, Daisenberger P, Mahling M et al (2011) Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Vet Clin Pathol 40:237\u2013244. https:\/\/doi.org\/10.1111\/j.1939-165X.2011.00305.x","journal-title":"Vet Clin Pathol"},{"key":"11408_CR112","doi-asserted-by":"publisher","unstructured":"Wurtinger G, Henrich E, Hildebrandt N et al (2017) Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats. BMC Vet Res 13:394. https:\/\/doi.org\/10.1186\/s12917-017-1319-6","DOI":"10.1186\/s12917-017-1319-6"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-026-11408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-026-11408-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-026-11408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:55:07Z","timestamp":1789790107000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-026-11408-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11408"],"URL":"https:\/\/doi.org\/10.1007\/s11259-026-11408-9","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"465"}}